{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:57Z","timestamp":1791357357409,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.biopsych.2012.03.022","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T20:45:18Z","timestamp":1335300318000},"page":"405-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse"],"prefix":"10.1016","volume":"72","author":[{"given":"Claus J.","family":"Loland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluyomi M.","family":"Okunola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kopajtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.03.022_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2011.02.009","article-title":"Neuroscience of behavioral and pharmacological treatments for addictions","volume":"69","author":"Potenza","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2012.03.022_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.bcp.2010.12.017","article-title":"Translational research in addiction: Toward a framework for the development of novel therapeutics","volume":"81","author":"Paterson","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nrd2828","article-title":"Development of pharmacotherapies for drug addiction: A Rosetta Stone approach","volume":"8","author":"Koob","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2012.03.022_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: Potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J Clin Psychiat"},{"key":"10.1016\/j.biopsych.2012.03.022_bib5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: A review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1874473710801020213","article-title":"Modafinil: a useful medication for cocaine addiction?","volume":"1","author":"Martinez-Raga","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.biopsych.2012.03.022_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2012.03.022_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.03.022_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pbb.2011.04.017","article-title":"Cognitive enhancers in the treatment of substance use disorders: Clinical evidence","volume":"99","author":"Brady","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2012.03.022_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","article-title":"Cognitive enhancing effects of modafinil in healthy volunteers","volume":"165","author":"Turner","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib11","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2010.83","article-title":"Modulatory effects of modafinil on neural circuits regulating emotion and cognition","volume":"35","author":"Rasetti","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/npp.2010.233","article-title":"Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals","volume":"36","author":"Ghahremani","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib13","first-page":"349","article-title":"Mechanisms of modafinil: A review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.biopsych.2012.03.022_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.biopsych.2012.03.022_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2012.03.022_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2012.03.022_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues","volume":"2","author":"Cao","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.biopsych.2012.03.022_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.biopsych.2012.03.022_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02247379","article-title":"Evaluation of the cocaine like discriminative stimulus effects and reinforcing effects of modafinil","volume":"126","author":"Gold","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2007.03.044","article-title":"Modafinil evokes striatal [H-3]dopamine release and alters the subjective properties of stimulants","volume":"568","author":"Dopheide","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbr.2009.05.028","article-title":"Modafinil reinstates a cocaine conditioned place preference following extinction in rats","volume":"204","author":"Bernardi","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2012.03.022_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pbb.2010.03.006","article-title":"Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents","volume":"95","author":"Paterson","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2012.03.022_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1037\/a0021042","article-title":"Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys","volume":"18","author":"Newman","year":"2010","journal-title":"Exp Clin Psychopharm"},{"key":"10.1016\/j.biopsych.2012.03.022_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10401230490453743","article-title":"Modafinil: Preclinical, clinical, and post-marketing surveillance\u2014a review of abuse liability issues","volume":"16","author":"Myrick","year":"2004","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.022_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2009.09.002","article-title":"Modafinil does not serve as a reinforcer in cocaine abusers","volume":"106","author":"Vosburg","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.03.022_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00007691-200304000-00009","article-title":"Chiral analysis of d- and l-modafinil in human serum: Application to human pharmacokinetic studies","volume":"25","author":"Donovan","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.biopsych.2012.03.022_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/00912709922007534","article-title":"A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers","volume":"39","author":"Wong","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","article-title":"Clinical pharmacokinetic profile of modafinil","volume":"42","author":"Robertson","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.biopsych.2012.03.022_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/030079906X80378","article-title":"Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss","volume":"22","author":"Dinges","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.biopsych.2012.03.022_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/11203290-000000000-00000","article-title":"Armodafinil","volume":"23","author":"Garnock-Jones","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2012.03.022_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/7355_2008_027","article-title":"Atypical dopamine uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter","volume":"4","author":"Newman","year":"2009","journal-title":"Top Med Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: Behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib34","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1073\/pnas.032386299","article-title":"Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle","volume":"99","author":"Loland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.03.022_bib35","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1074\/jbc.M304755200","article-title":"Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding","volume":"279","author":"Loland","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2012.03.022_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","article-title":"The binding sites for benztropines and dopamine in the dopamine transporter overlap","volume":"60","author":"Bisgaard","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib39","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","article-title":"Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the \u201cshell\u201d as compared with the \u201ccore\u201d of the rat nucleus accumbens","volume":"92","author":"Pontieri","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.03.022_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.03.022_bib41","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu 1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.03.022_bib42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.109.154302","article-title":"Combinations of cocaine with other dopamine uptake inhibitors: Assessment of additivity","volume":"330","author":"Tanda","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2012.03.022_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.110.173260","article-title":"N-substituted benztropine analogs: Selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects","volume":"336","author":"Li","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2012.03.022_bib45","doi-asserted-by":"crossref","first-page":"17691","DOI":"10.1074\/jbc.M800475200","article-title":"An intracellular interaction network regulates conformational transitions in the dopamine transporter","volume":"283","author":"Kniazeff","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.03.022_bib47","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.95.16.9238","article-title":"Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter","volume":"95","author":"Ferrer","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.03.022_bib48","doi-asserted-by":"crossref","first-page":"29012","DOI":"10.1074\/jbc.M011785200","article-title":"The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter","volume":"276","author":"Reith","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.97.3.1044","article-title":"Permeation and gating residues in serotonin transporter","volume":"97","author":"Chen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.03.022_bib50","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.03.022_bib51","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1124\/mol.106.026120","article-title":"A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter\/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function","volume":"70","author":"Beuming","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1152\/physiol.00030.2009","article-title":"The rocking bundle: A mechanism for ion-coupled solute flux by symmetrical transporters","volume":"24","author":"Forrest","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl\u2014dependent neurotransmitter transporters","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.03.022_bib54","doi-asserted-by":"crossref","first-page":"e25790","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.biopsych.2012.03.022_bib55","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/jm00020a006","article-title":"Novel 4'-substituted and 4',4''-disubstituted 3-alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors","volume":"38","author":"Newman","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2012.03.022_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/syn.1108","article-title":"Non-amines, drugs without an amine nitrogen, potently block serotonin transport: Novel antidepressant candidates?","volume":"42","author":"Goulet","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2012.03.022_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2003.08.055","article-title":"Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors","volume":"479","author":"Madras","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-002-1080-8","article-title":"Study of the addictive potential of modafinil in naive and cocaine-experienced rats","volume":"161","author":"Deroche-Gamonet","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-200203000-00002","article-title":"Acute behavioral and physiological effects of modafinil in drug abusers","volume":"13","author":"Rush","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2012.03.022_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-005-0044-1","article-title":"Reinforcing effects of modafinil: Influence of dose and behavioral demands following drug administration","volume":"182","author":"Stoops","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.022_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/11315280-000000000-00000","article-title":"Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives analysis of data from three randomized, single-dose, pharmacokinetic studies","volume":"29","author":"Darwish","year":"2009","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.biopsych.2012.03.022_bib63","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.clinthera.2010.11.009","article-title":"Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study","volume":"32","author":"Darwish","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.biopsych.2012.03.022_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000446","article-title":"Lost in translation: Neuropsychiatric drug development","volume":"2","author":"Becker","year":"2010","journal-title":"Science Transl Med"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:59:40Z","timestamp":1762099180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0006322312002715"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.03.022","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}